Chicago Trust CO Na Myriad Genetics Inc Transaction History

Chicago Trust CO Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$22.67 - $28.01 $170,025 - $210,075	-7,500 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$29.97 - $36.66 $59,940 - $73,320	-2,000 Reduced 21.05%	7,500 $242,000
Q1 2021 Apr 12, 2021	BUY	$19.92 - $31.6 $189,240 - $300,200	9,500 New	9,500 $289,000
Q1 2020 Apr 07, 2020	SELL	$9.78 - $29.53 $92,910 - $280,535	-9,500 Closed	0 $0
Q3 2019 Oct 09, 2019	BUY	$22.08 - $47.08 $44,160 - $94,160	2,000 Added 26.67%	9,500 $272,000
Q4 2018 Jan 09, 2019	BUY	$27.23 - $45.56 $68,075 - $113,900	2,500 Added 50.0%	7,500 $218,000
Q3 2018 Oct 10, 2018	BUY	$37.57 - $50.34 $187,850 - $251,700	5,000 New	5,000 $230,000

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.18B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Chicago Trust CO Na with notifications on news.